1.
Antimicrob Agents Chemother
; 56(1): 563-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22005993
RESUMO
The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.